← Back to Clinical Trials
Recruiting NCT02527486

NCT02527486 Seoul National University Airway Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02527486
Status Recruiting
Phase
Sponsor Seoul National University Hospital
Condition Chronic Obstructive Pulmonary Disease (COPD)
Study Type OBSERVATIONAL
Enrollment 800 participants
Start Date 2011-09
Primary Completion 2021-12

Trial Parameters

Condition Chronic Obstructive Pulmonary Disease (COPD)
Sponsor Seoul National University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 800
Sex ALL
Min Age 20 Years
Max Age 90 Years
Start Date 2011-09
Completion 2021-12

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a multicenter, prospective observational cohort study, in which patients with chronic airway diseases including chronic obstructive pulmonary disease(COPD), asthma, asthma-COPD overlap syndrome (ACOS) will be recruited.

Eligibility Criteria

COPD Inclusion Criteria: * Postbronchodilator FEV1/FVC \< 0.7 AND chronic respiratory symptom Exclusion Criteria: \- Asthma Inclusion Criteria: * Never smoker or \<5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test) Exclusion Criteria: \- ACOS Inclusion Criteria: * COPD AND Asthma (regardless of smoking status) Exclusion Criteria: \-

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology